CompletedNCT00211419
Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)
PHASE1 · planned enrolment not reported
- Countries listed
- 1
- Registry update
- October 24, 2012
